Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Specific investigations: other studies

Currently viewing:

Administrative data

Endpoint:
biochemical or cellular interactions
Type of information:
other: experimental result
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Acceptable, well-documented publication/study report which meets basic scientific principles

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1986
Report date:
1986

Materials and methods

Test guideline
Qualifier:
no guideline available
Principles of method if other than guideline:
Effects of DEHP and five of its metabolites including 2-EH on rat testis in vivo and in vitro
GLP compliance:
not specified
Endpoint addressed:
toxicity to reproduction / fertility

Test material

Constituent 1
Chemical structure
Reference substance name:
Bis(2-ethylhexyl) phthalate
EC Number:
204-211-0
EC Name:
Bis(2-ethylhexyl) phthalate
Cas Number:
117-81-7
Molecular formula:
C24H38O4
IUPAC Name:
bis(2-ethylhexyl) phthalate
Details on test material:
- Name of test material (as cited in study report):

- 2-EH

- Other test substances examined in the same study:

DEHP
MEHP
Metabolite IX (mono-2-ethyl-hexanol-6-hexanoic acid)-phthalate; w-oxidation product of MEHP)
Metabolite VI (mono-2-ethyl-5-keto-hexanol)-phthalate
Metabolite V (mono-2-ethyl-5-hydroxy-hexanol)-phthalate

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
other: propylene glycol (MEHP and MEHP-metabolites; DEHP and 2-EH: suspension without vehicle
Duration of treatment / exposure:
5 exposures
Frequency of treatment:
1/day
Doses / concentrations
Remarks:
Doses / Concentrations:
2.7 mmol/kg bw/day
Basis:
actual ingested
No. of animals per sex per dose:
6 animals per test substance
Control animals:
yes, concurrent vehicle

Examinations

Examinations:
In vivo: metabolite blood levels (excluding 2-EH). Absolute and relative testes and prostate weight; degenerate dcells in seminiferous tubules.
In vitro: germ cell detachment in primary rat testicular cell cultures.

Results and discussion

Details on results:
Degeneration of testes and Sertoli cells were not associated with 2 -EH, but with MEHP, which is generated following the administration of DEHP.

Any other information on results incl. tables

In vivo: Five of six rats receiving MEHP had a much higher frequency of degenerating cells (degenerated spermatocytes and spermatids) in the seminiferous tubules, compared to the control animals or rats receiving DEHP, 2 -EH, or the metabolites of MEHP. Therefore, no testicular damage was observed in animas given 2 -EH.
In vitro: Germ cell detachment was significantly increased in primary rat testicular cell cultures when MEHP was adminsitered at concnetrations oft 1 µM and above (Table). DEHP and 2 -EH administered at 200 µM were not different from controls at 24 and 48 hours.

Applicant's summary and conclusion

Conclusions:
MEHP is the metabolite that is responsible for the testicular damage that is observed following administration of DEHP to rats.
2-EH has no adeverse effect on testis, germ cell detachment in vivo or in vitro.
Executive summary:

In was shown vivo and also in primary rat testicular cell cultures in vitro that MEHP was the metabolite that causes testicular damage following administration of DEHP. MEHP caused a significantly increased germ cell detachment in vitro at 1 µM and above, whereas effcts of 200 µM DEHP and 2 -EH were not different from controls after 24 or 48 hour incubation in vitro (Sjöberg et al., 1986).